The Viral Trigger
Exploring the connection between EBV and MS
Client:
Moderna
Project:
EBV Vaccine Clinical Trial
Scope:
Concept Development
Global reach:
United States
Emerging research suggests that Epstein-Barr virus (EBV) may be a key factor in triggering MS, offering new hope for understanding and potentially preventing the disease.
These concepts explore options for a clinical trial recruitment campaign aimed at people living with MS. Primary audience is a 25-45 year old womn in the prime of her life concerned with advancing MS symptoms but potential unaware of the relevance Epstein-Barr Virus might play in their advanceent.
Solve the mystery
Bringing the connection between EBV and MS to the forefront. The split-brain design represents the intersection of neurology and virology, with the plus sign symbolizing breakthrough research. The tagline, "Working to solve the MyStery," reinforces the pursuit of answers while subtly emphasizing MS. This concept positions the clinical trial as a key step in exploring an EBV vaccine’s potential to impact MS progression.
Never see it coming
Many people with Multiple Sclerosis (MS) may not realize that the Epstein-Barr Virus (EBV) could be silently driving their disease progression. This concept brings that hidden threat to life, depicting a massive EBV virus looming behind an unaware individual as she goes about her daily routine.
In motion
The blurred motion effect surrounding the central figure represents the uncertainty of Multiple Sclerosis (MS)—a condition that can progress unexpectedly, often without warning. The question, "When will EBV set your MS in motion?", reinforces the growing evidence that Epstein-Barr Virus (EBV) may trigger or accelerate MS, creating an urgent need for research.
Focus on MS
A quiet moment of reflection contrasts with the invisible presence of Epstein-Barr Virus (EBV), visually represented by the overlay of a virus-like targeting frame around the woman. This concept underscores the uncertainty of MS relapses and the potential role of EBV in disease progression.
